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Abstract: Background: Automated cerebrospinal fluid (CSF) drainage systems allow for the mobiliza-
tion of patients with an external CSF drain. The aim of this study is to describe the implementation
of an automated CSF drainage system in neurosurgical patients with external CSF drains. Meth-
ods: A feasibility study was performed using an automated CSF drainage system (LiquoGuard®7,
Möller Medical GmbH, Fulda, Germany) in adult neurosurgical patients treated with external lum-
bar or external ventricular drains between December 2017 and June 2020. Limited mobilization
was allowed—patients were allowed to adjust their inclined beds, sit in chairs and walk under the
supervision of a nurse or physical therapist. The primary outcome was the number of prematurely ter-
minated drainage sessions. Results: Twenty-three patients were included. Drainage was terminated
prematurely in eight (35%) patients. In three (13%) of these patients, drainage was terminated due to
signs of hydrocephalus. Pressure-controlled drainage in patients with external lumbar drains (ELD)
showed inaccurate pressure curves, which was solved by using volume-controlled drainage in ELD
patients. Conclusion: The implementation of an automated CSF drainage system (LiquoGuard®7) for
CSF drainage allows for early mobilization in a subset of patients with external CSF drains. External
lumbar drains require volume-based drainage rather than differential pressure-dependent drainage.
Keywords: external cerebrospinal fluid drain; LiquoGuard®7; hydrocephalus
1. Introduction
Temporary treatment of hydrocephalus using external lumbar or ventricular drainage
is common in neurosurgical practice. Conventional hydrostatic pressure-controlled drainage
with dripping chambers are the gold standard [1]. However, using dripping chambers re-
stricts patient mobility and can cause unintentional over- or underdrainage during Valsalva
manoeuvres or patient movement. Patients are therefore immobilized during drainage.
It has been shown that early mobilization decreases the complications associated
with immobilization, results in a shorter length of hospital stay and seems to be safe
for patients with an external cerebrospinal fluid (CSF) drain [2–7]. To prevent over- and
underdrainage, external drains are clamped during mobilization and require continuous
intracranial pressure monitoring (ICP), which limits mobilization time [5–7].
The LiquoGuard®7 (Möller Medical GmbH, Fulda, Germany), is an automated cere-
brospinal fluid (CSF) drainage system that has been available since 2011. It acts as a
self-adjusting, pressure-based resistor that allows CSF to drain in a controlled manner, and
is thus intended to prevent over- or underdrainage [1]. The system is designed to enable
early mobilization of patients. Its use is described in patients requiring CSF drainage
due to thoracoabdominal aortic aneurysm repair and in neurosurgical patients requiring
ICP pressure regulation [1,8–10]. However, to our knowledge, its capacity to facilitate the
mobilization of neurosurgical patients has not been previously described.
Brain Sci. 2021, 11, 683. https://doi.org/10.3390/brainsci11060683 https://www.mdpi.com/journal/brainsci
Brain Sci. 2021, 11, 683 2 of 8
The aim of this study is to describe the implementation of the LiquoGuard®7 in
mobilized hydrocephalus patients with external CSF drains.
2. Materials and Methods
This feasibility study was performed in accordance with the ethical standards of
the institutional board review (NL62883.091.17). From December 2017 until June 2020,
adult neurosurgical patients (>18 years) treated with an external ventricular drain (EVD,
CODMAN® BACTISEAL® EVD Catheter, Johnson & Johnson, Raynham, MA, USA) or an
external lumbar drain (ELD, Perifix® epidural catheter, B Braun, Melsungen AG, Germany)
were included.
Two LiquoGuard®7 systems (Möller Medical GmbH, Fulda, Germany) were used.
The device is an automated pressure-based CSF drainage system connected to the EVD
or ELD catheter. It measures ICP by using a pressure sensor that is fixed by an electrocar-
diogram sticker on the skin over the temporal bone at the height of the foramen of Monro
(Figure 1) [9].
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Figure 1. Set-up of the LiquoGuard®7 in a patient treated with an EVD. The pressure sensor is
attached to the skin by an electrocardiogram sticker at the height of the foramen of Monro.
The manufacturer gave instruction on the theoretical background of the device and its
practical use to all caregivers. The first author (S.A.) and a nurse practitioner were available
to answer remaining questions during the implementation and to provide assistance to
daily caregivers. User manuals, in the form of flowcharts, were also attached to eachsystem.
The placement of the EVDs and ELDs was performed according to the institutional
standard insertion protocol. At the intensive care unit (ICU), patients were treated
with a conventional drainage system (Duet™ External Drainage and Monitoring Sys-
tem, Medtronic, Minneapolis, MN, USA). After transfer to the neurosurgical ward, the
LiquoGuard®7 was installed if written and verbal informed consent was obtained from
patients, or their legally authorised representatives. Patients were included in the study on
a first-come, first-served basis, due to restricted availability of the system.
Two drainage modes are available for the LiquoGuard®7—pressure-regulated drainage
and volume-regulated drainage. In this study, pressure-regulated drainage was used.
In pressure-regulated drainage, the system drains CSF as soon as intracranial pressure
exceeds the pre-set pressure value. The device produces an audible alarm when pre-set
alarm limits are exceeded. Our conventional system is calibrated at 10 cm above the
foramen of Monro per institutional protocol. Accordingly, the use pre-set pressure value
for the LiquoGuard®7 was set to 10 cmH2O, with an alarm range between −10 cmH2O
and 20 cmH2O. In volume-regulated drainage, the system drains a pre-set volume of CSF
per hour, reg dless of intracranial pressure. Accord ng to the instructions f r use, the
diameter of the lumen of the EVD and ELD atheters used needed to be more than 0.7 mm
in order to measure CSF pressure correctly.
Mobilization was encouraged as much as was clinically possible. Patients received
physical therapy once a day and were seated for at least thirty minutes, three times a
day. Furthermore, patients were allowed to adjust their inclined bed and walk under the
supervision of a nurse.
The primary outcome was the number of prematurely terminated drainage sessions
with the LiquoGuard®7. Reasons for termination were described. Complications were
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included as secondary outcome measures and were registered if they occurred between the
placement of the first drain and 30 days after removal of the last drain.
Complications were defined according to our earlier study regarding complications
of external CSF drainage in aneurysmal subarachnoid haemorrhage (aSAH) [11], and
were divided into direct and indirect complications. Direct complications were defined
as complications with a direct relation to the external CSF drain (i.e., drain dislodgement,
drain occlusion and meningitis). Indirect complications were defined as complications
that could not be directly related to the external CSF drainage. These indirect medical
complications were divided into four subgroups: infection, delirium, pressure injuries
and thromboembolic complications. The number of internal shunts after external drain
placement was also registered. Thromboembolic processes were subdivided into deep-vein
thrombosis and pulmonary embolisms. Deep-vein thrombosis consisted of a confirmed
diagnosis by echo-Doppler, while for pulmonary embolisms a confirmed diagnosis by
spiral-CT scan was required. Delirium was registered as a complication when patients had
clinical signs of delirium in accordance with the Delirium Observation Scale, for which
haloperidol was given [12]. Pressure injuries were defined by the pressure injury grading
score as stated by the National Pressure Ulcer Advisory Panel in 2016 [13]. Infections were
only registered as complications if antibiotic treatment was started. An infection was de-
tected by monitoring the clinical condition of the patient combined with a rising C-reactive
protein and leukocyte count or positive cultures. The EVDs or ELDs were considered to be
dislodged when the drains were inadvertently partially or entirely removed. Occlusion
was registered as a complication if drain reimplantation was needed.
Patient-specific data were retrieved from the digital patient information system (Epic
Systems Corporation (2014), Madison, WI, USA). Information regarding demographics,
drainage period, drain type, length of hospital stay, destination after discharge and compli-
cations were prospectively registered.
All data were analysed using IBM SPSS Statistics for Windows (Version 22.0. IBM
Corp., Armonk, NY, USA). Continuous data were presented as median and range. Categor-
ical data were presented as counts and percentages.
3. Results
Twenty-three patients were included (Table 1). Nineteen EVDs and five ELDs were
connected to the LiquoGuard®7 (one patient received an ELD after the EVD was removed).
The median time from drain placement until mobilization (connection to the LiquoGuard®7)
was three (0–20) days, with a median mobile period of six days (Table 1).
Twenty-eight complications occurred in 14 patients (61%). A total of nine direct
complications and 19 indirect complications occurred in these patients, with a median of
one (0–4) complication per patient (Figure 2, Table 2).
One drain dislodgement occurred while connected to the LiquoGuard®7. LiquoGuard®7′s
tubing set occluded twice. In these cases, the LiquoGuard®7 was removed instead of
being replaced.
The LiquoGuard®7 was disconnected prematurely in eight patients (35%) (Table 3).
The first patient treated with the system became clinically unstable due to multi-organ
failure and was reconnected to the conventional system. Any causal link with the device
was excluded.
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Table 1. Demographics data are presented as counts or median and range.
Total (n)
Number of Patients 23





ICH * 5 (22%)





Number of Drains 1 (1–2)
Total Drainage Period (days) 13 (7–41)
Drainage Period LG (days) 6.0 (1–16)
Drainage Period before Connected to LG (days) 3.0 (0–20)
Length of Stay (days) 18 (12–45)
ASA * 2 (1–3)
VPD * 5
* M: male; F: Female; ICH: intracerebral haemorrhage; LG: LiquoGuard®7; ASA: American Society of Anaesthesi-
ology score; VPD: ventriculoperitoneal drain.
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Table 2. Complications.








Pressure Injuries 5 (13%)
Thromboembolic Process 2 (5.3%)
Total 28 (100%)
Table 3. Reasons for LiquoGuard®7 removal.
Number Percentage
Successful Challenge 13 57%
Clinically Instable 1 4.3%
Technical Problems 1 4.3%
Signs of Hydrocephalus 3 13%
Distal Occlusion 2 8.7%
Drain Dislodgement 1 4.3%
Other * 2 8.7%
* Other consists of one VPD insertion and one discharge to another department.
Although the lumen of the ELD tubing set used was more than 0.7 mm, it was
observed that the pressure curves were not accurate in the first patient with an ELD. No
pulsation was measured, and the pressures shown were constantly negative, even in supine
position. As a result, the device did not drain the desired amount of CSF, which lead to
underdrainage. After contacting a technical expert from the manufacturer, the drainage
mode in patients treated with an ELD was set to volume-regulated with a pre-set volume
of 10 mL/h, which solved the problem.
Despite pressure or volume measurements within limits and normal pulsations,
three patients neurologically deteriorated while being drained with the LiquoGuard®7
(Table 4). All three patients showed clinical improvement after changing to a conventional
drainage system.
Table 4. The characteristics of patients that showed signs of hydrocephalus during drainage with the LiquoGuard®7.










2 61 aSAH 1 ELD 2 19 16 Headache and CSFleakage along drain 3
3 72 PMH * N/A ELD 1 8 1 Headache 0
* DP: drainage period; LG: LiquoGuard®7; PMH: perimesencephalic haemorrhage.
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4. Discussion
Neurological deterioration due to hydrocephalus occurred three times despite drainage
systems being functional. This suggested that settings different from a normal overflow
system, depending on hydrostatic pressure, might be required.
Patients with conventional external CSF drainage systems tend to moderately over-
drain CSF, which occurs especially during manoeuvres that cause a short increase in
intracranial pressure, for example coughing, leg elevation, positional changes or speaking.
This overdrainage is prevented by the LiquoGuard®7, which may contribute to the ob-
served neurological deterioration in some patients. Measuring ICP exclusively is possibly
insufficient for maintaining CSF homeostasis, due to normal pressure hydrocephalus in
aSAH patients [14,15]. Since the majority of patients in this series suffered from aSAH,
normal pressure hydrocephalus might have contributed to the relatively high number of
premature disconnections.
It may be that standardized pressure settings in these patients are insufficient. To
overcome this problem, lowering the pressure settings stepwise or switching to volume-
controlled drainage may help to drain sufficient amounts of CSF.
Additionally, when patients are in an upright position the physiological intracranial
pressure can become negative, varying with exercise or movement [16,17]. This may result
in underdrainage during mobilization, as pressure settings remain unchanged during
mobilization. One would expect this relative underdrainage to be corrected during bed
rest. However, this correction did not occur. This supports the idea that the regulation of
CSF dynamics is complex and cannot always be limited exclusively to pressure or flow
control in a mobilized patient. Continuous flow may be very important for maintaining an
equilibrium in CSF homeostasis.
Although inaccurate pressure curves are a well-known phenomenon, the reason for
inaccurate pressure curves in patients treated with an ELD is unknown. It is remarkable
that previous literature regarding thoracic surgery shows adequate pressure measurements
in lumbar drainage [8,10]. Although not described, it may be the case that, in these studies,
pressure sensors were attached near the ELD insertion place. Since patients were mobilized
in our study, the pressure sensor was attached at the height of the foramen of Monro,
so pressure waves might not have been conducted well through the longer catheter. A
second possible explanation is that intracranial haemorrhage compartmentalization of CSF
may occur, which results in a discrepancy between measured spinal CSF pressure and
intracranial CSF pressure.
Previous studies describe that the LiquoGuard®7 shows inappropriate curves and
drains an inadequate amount of fluid from patients with slit ventricles [1,9]. In this study,
no patients suffered from slit ventricles and, therefore, no experience was gained on this
potential problem.
It is unclear which patient will benefit the most from automated CSF drainage with the
LiquoGuard®7. Pressure and volume settings seem patient specific and underlying factors
are currently unknown, which hampers patient selection for automated CSF drainage.
The incidence of meningitis is relatively high and not related to drainage time [18];
however, due to the small number of patients, no conclusions can be drawn concern-
ing the number of complications. However, we have reported on all types of compli-
cations for transparency reasons. Theoretically, using the LiquoGuard®7 could lead to
a decline in complications since mobilized patients might be less prone to secondary
complications [2,3,5–7].
While shunt dependency in this study seemed slightly higher in comparison to our
earlier series regarding complications in patients treated with a conventional EVD or
ELD system (22% in this study versus 15%) [11], future studies should compare patients
that receive automated CSF drainage and drainage with a conventional system. The
sample size of the present study is small; however, the presented results are beneficial
for other neurosurgical departments planning to implement the LiquoGuard®7 in their
clinical practise.
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5. Conclusions
The implementation of an automated CSF drainage system (LiquoGuard®7) for CSF
drainage allows early mobilization in a subset of patients with an external CSF drain.
External lumbar drains require a volume-based drainage rather than a differential pressure-
dependent drainage.
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